Intralymphatic histiocytosis. a clinicopathologic study of 16 cases

Luis Requena, Laila El-Shabrawi-Caelen, Sarah N. Walsh, Sonia Segura, Mirjana Ziemer, Mark A. Hurt, Omar P. Sangüeza, Heinz Kutzner

    Research output: Contribution to journalArticleResearchpeer-review

    80 Citations (Scopus)


    Intralymphatic histiocytosis is a rare condition characterized by the presence of dilated lymphatic vessels containing aggregates of mononuclear histiocytes (macrophages) within their lumina. The phenomenon seems to occur almost exclusively within the reticular dermis. Although its pathogenesis remains uncertain, there has been speculation about the possible relationship between intralymphatic histiocytosis and intravascular reactive angioendotheliomatosis. In addition, several examples historically have been associated with rheumatoid arthritis. We describe our experience with 16 cases of intralymphatic histiocytosis. Clinically, the lesions were located predominantly on the upper and lower limbs, and they consisted of asymptomatic and poorly demarcated erythematous plaques and livedo reticularis-like lesions. They were characterized histopathologically by dilated vascular structures involving the reticular dermis. Some of these dilated vessels had empty lumina, whereas others contained variable number of mononuclear histiocytes. An inflammatory response of variable intensity from case to case was also present in the adjacent dermis. The dilated vessels exhibited thin walls with irregular shapes, and a single discontinuous layer of flat endothelial cells lined their lumina. Immunohistochemically, the endothelial cells lining the dilated lumina expressed immunoreactivity for CD31, CD34, podoplanin, D2-40, Lyve-1, and Prox-1, which confirmed their nature as lymphatic endothelial cells. Intralymphatic mononuclear histiocytes expressed CD68 (PGM1), although some cases also had variable immunoexpression for myeloperoxidase, CD31, and podoplanin. In the 4 cases that employed double immunohistochemistry, with podoplanin + CD68 (PGM1) or with Lyve-1 + CD68 (PGM1), each marker highlighted their specific target cells unequivocally; the endothelial cells expressed podoplanin or Lyve-1 immunoreactivity, and intralymphatic histiocytes showed CD68 (PGM1) immunoexpression. Our findings expand on the previously described morphologic and immunohistochemical features of intravascular histiocytosis. We also discuss the possible relationship between intralymphatic histiocytosis and the so-called reactive intravascular angioendotheliomatosis. © 2009 by Lippincott Williams & Wilkins.
    Original languageEnglish
    Pages (from-to)140-151
    JournalAmerican Journal of Dermatopathology
    Issue number2
    Publication statusPublished - 1 Apr 2009


    • Breast carcinoma
    • Immunohistochemistry
    • Intralymphatic histiocytosis
    • Intralymphatic macrophages
    • Intravascular lymphoma
    • Lymphatic endothelial cell markers
    • Reactive intravascular angioendotheliomatosis
    • Rheumatoid arthritis


    Dive into the research topics of 'Intralymphatic histiocytosis. a clinicopathologic study of 16 cases'. Together they form a unique fingerprint.

    Cite this